JENNY STONE: Open Payments
NPI 1245207901 · SPARTA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 40 payments from 11 companies in 2025. Trend: 2023 $711 · 2024 $889 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $198 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| ABBVIE INC. | 5 | $83 |
| Supernus Pharmaceuticals, Inc. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| Acella Pharmaceuticals, LLC | 4 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Tris Pharma Inc | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
Products named: REXULTI, UZEDY, ABILIFY MAINTENA, VRAYLAR, Qelbree, CAPLYTA, NP Thyroid 60, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
